256 related articles for article (PubMed ID: 30222644)
1. Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.
Ramai D; Etienne D; Ayide G; Fields PJ; Reddy M
J Clin Gastroenterol; 2019; 53(10):744-749. PubMed ID: 30222644
[TBL] [Abstract][Full Text] [Related]
2. A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings.
Christy SM; Davis SN; Williams KR; Zhao X; Govindaraju SK; Quinn GP; Vadaparampil ST; Lin HY; Sutton SK; Roethzeim RR; Shibata D; Meade CD; Gwede CK
Cancer; 2016 Nov; 122(21):3288-3296. PubMed ID: 27420119
[TBL] [Abstract][Full Text] [Related]
3. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
[TBL] [Abstract][Full Text] [Related]
4. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
[TBL] [Abstract][Full Text] [Related]
5. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.
Gordon NP; Green BB
BMC Public Health; 2015 Jun; 15():546. PubMed ID: 26062732
[TBL] [Abstract][Full Text] [Related]
7. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
8. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
[TBL] [Abstract][Full Text] [Related]
9. What are the contextual risk factors for low colorectal cancer screening uptake in El Paso County, Texas? Spatial cross-sectional analysis.
Salinas J; Brito J; Rincones C; Shokar NK
BMJ Open; 2020 Oct; 10(10):e038342. PubMed ID: 33040009
[TBL] [Abstract][Full Text] [Related]
10. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Levin TR; Jensen CD; Chawla NM; Sakoda LC; Lee JK; Zhao WK; Landau MA; Herm A; Eby E; Quesenberry CP; Corley DA
Gastroenterology; 2020 Nov; 159(5):1695-1704.e1. PubMed ID: 32702368
[TBL] [Abstract][Full Text] [Related]
11. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
Davis SN; Christy SM; Chavarria EA; Abdulla R; Sutton SK; Schmidt AR; Vadaparampil ST; Quinn GP; Simmons VN; Ufondu CB; Ravindra C; Schultz I; Roetzheim RG; Shibata D; Meade CD; Gwede CK
Cancer; 2017 Apr; 123(8):1390-1400. PubMed ID: 27906448
[TBL] [Abstract][Full Text] [Related]
13. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
[TBL] [Abstract][Full Text] [Related]
14. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
[TBL] [Abstract][Full Text] [Related]
15. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.
Gupta S; Coronado GD; Argenbright K; Brenner AT; Castañeda SF; Dominitz JA; Green B; Issaka RB; Levin TR; Reuland DS; Richardson LC; Robertson DJ; Singal AG; Pignone M
CA Cancer J Clin; 2020 Jul; 70(4):283-298. PubMed ID: 32583884
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
Salimzadeh H; Bishehsari F; Sauvaget C; Amani M; Hamzehloo G; Nikfarjam A; Merat S; Delavari A; Malekzadeh R
Arch Iran Med; 2017 Dec; 20(12):726-733. PubMed ID: 29664311
[TBL] [Abstract][Full Text] [Related]
17. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
[No Abstract] [Full Text] [Related]
18. Patient Test Preference for Colorectal Cancer Screening and Screening Uptake in an Insured Urban Minority Population.
Wolf RL; Basch CE; Zybert P; Basch CH; Ullman R; Shmukler C; King F; Neugut AI
J Community Health; 2016 Jun; 41(3):502-8. PubMed ID: 26585609
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a home-based colorectal cancer screening intervention in a rural state.
Charlton ME; Mengeling MA; Halfdanarson TR; Makki NM; Malhotra A; Klutts JS; Levy BT; Kaboli PJ
J Rural Health; 2014; 30(3):322-32. PubMed ID: 24164375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
